Healshape is a regenerative medecine project. We aim at developing breast regeneration solutions by 3D bioprinting for women who had mastectomy following breast cancer.
Location: France, Auvergne-Rhone-Alpes, Villeurbanne
Employees: 11-50
Founded date: 2020
Investors 1
| Date | Name | Website |
| 09.08.2022 | Demeter | demeter-im... |
Mentions in press and media 8
| Date | Title | Description |
| 20.01.2025 | BellaSeno reports successful trial results for its resorbable breast scaffolds | German medical startup BellaSeno has shared promising results from its Australian clinical trials leveraging resorbable breast implants. These proposed studies assessed the use of biodegradable polycaprolactone (PCL) scaffolds as an alterna... |
| 31.05.2022 | Regemat 3D raises over €500k in effort to advance its 3D bioprinting technology | Spanish 3D bioprinting specialist Regemat 3D has raised more than €500,000 in equity crowdfunding. Announced late last year, the funding round has seen Regemat 3D gain the backing of over 500 investors, for its plans to ramp up the marketin... |
| 04.05.2022 | BICO board declares that it has “full confidence” in CEO despite 41% plunge in share price | 3D bioprinting firm BICO’s board has thrown its weight behind the company’s under-fire CEO Erik Gatenholm after mismanagement allegations being raised against him by a former employee and anonymous sources. In an article published on April ... |
| 31.03.2022 | CollPlant to trial 3D bioprinted breast implants in breakthrough animal study | Regenerative medicine specialist CollPlant (NASDAQ: CLGN) has revealed that the 3D bioprinted breast tissues it’s developing are set to enter animal trials in the very near future. Alongside the release of its FY 2021 results, which show th... |
| 23.02.2022 | CollPlant partners with CELLINK in bid to address $2.8BN regenerative breast implant market | Regenerative medicine specialist CollPlant has partnered with BICO firm CELLINK in an effort to ramp up its production of 3D bioprinted breast implants. Currently undergoing preclinical trials, CollPlant’s bioprinted grafts are designed to ... |
| 02.02.2022 | Nuclera raises $42.5M towards launch of new protein 3D printer that “makes drug discovery accessible” | Insiders and analysts have made their predictions on the 3D printing trends to watch out for. Find out more in our series focused on the future of 3D printing. Biotechnology start-up Nuclera has raised $42.5 million towards the launch of a ... |
| 31.01.2022 | Matricelf licenses patent for 3D bioprinting tissues and organs from TAU | Israeli regenerative medicine firm Matricelf has signed an exclusive global licensing agreement with Tel Aviv University (TAU) technology transfer firm Ramot for a patent-pending 3D bioprinting technology. According to Globes, the technique... |
| 20.01.2022 | Healshape to raise $6.8M to advance its breast implant 3D bioprinting technology | Insiders and analysts predict the 3D printing trends to watch in our latest series of articles focused on the future of 3D printing. Healshape, a Lyon, France-based regenerative medicine startup, is expecting to raise $6.8 million in Series... |